Philippe Backeljauw

6.2k total citations · 1 hit paper
118 papers, 3.2k citations indexed

About

Philippe Backeljauw is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Philippe Backeljauw has authored 118 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Endocrinology, Diabetes and Metabolism, 47 papers in Molecular Biology and 46 papers in Genetics. Recurrent topics in Philippe Backeljauw's work include Growth Hormone and Insulin-like Growth Factors (55 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (26 papers) and Sexual Differentiation and Disorders (23 papers). Philippe Backeljauw is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (55 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (26 papers) and Sexual Differentiation and Disorders (23 papers). Philippe Backeljauw collaborates with scholars based in United States, United Kingdom and Germany. Philippe Backeljauw's co-authors include Louis E. Underwood, Iris Gutmark‐Little, Karen O. Klein, Claus Højbjerg Gravholt, Nelly Mauras, Steven D. Chernausek, Theo Sas, L E Underwood, Mitchell E. Geffner and N.H. Andersen and has published in prestigious journals such as Nature Genetics, Blood and Endocrine Reviews.

In The Last Decade

Philippe Backeljauw

113 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting

2017 663 citations Claus Højbjerg Gravholt, Mitchell E. Geffner et al. European Journal of Endocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philippe Backeljauw United States	28	1.4k	1.3k	1.2k	542	449	118	3.2k
Kirstine Stochholm Denmark	30	2.1k 1.5×	1.0k 0.8×	1.3k 1.1×	476 0.9×	515 1.1×	84	3.6k
Mariacarolina Salerno Italy	36	1.0k 0.7×	2.4k 1.9×	945 0.8×	541 1.0×	371 0.8×	160	3.7k
Kenneth M. Attie United States	35	1.2k 0.9×	2.3k 1.8×	2.0k 1.6×	718 1.3×	373 0.8×	85	4.5k
Alexander A.L. Jorge Brazil	36	1.7k 1.2×	1.5k 1.2×	2.0k 1.7×	330 0.6×	467 1.0×	185	3.8k
Andrew Dauber United States	31	1.3k 1.0×	962 0.7×	1.3k 1.1×	354 0.7×	241 0.5×	109	2.8k
Małgorzata Waśniewska Italy	32	965 0.7×	1.8k 1.4×	839 0.7×	387 0.7×	390 0.9×	204	3.5k
Marsha L. Davenport United States	27	1.2k 0.8×	1.1k 0.9×	1.2k 1.0×	422 0.8×	290 0.6×	52	2.9k
Barbara M. Lippe United States	36	1.4k 1.0×	1.8k 1.4×	1.4k 1.2×	685 1.3×	506 1.1×	99	4.0k
Cecilia Camacho‐Hübner United Kingdom	38	1.5k 1.1×	3.7k 2.8×	1.8k 1.5×	791 1.5×	627 1.4×	103	5.0k
Wilma Oostdijk Netherlands	36	1.1k 0.8×	1.8k 1.4×	1.5k 1.2×	914 1.7×	287 0.6×	121	3.7k

Countries citing papers authored by Philippe Backeljauw

Since Specialization

Citations

This map shows the geographic impact of Philippe Backeljauw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Backeljauw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Backeljauw more than expected).

Fields of papers citing papers by Philippe Backeljauw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Backeljauw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Backeljauw. The network helps show where Philippe Backeljauw may publish in the future.

Co-authorship network of co-authors of Philippe Backeljauw

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Backeljauw. A scholar is included among the top collaborators of Philippe Backeljauw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Backeljauw. Philippe Backeljauw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Juul, Anders, Philippe Backeljauw, Jan Frystyk, et al.. (2024). Somapacitan in Children Born SGA: 52-Week Efficacy, Safety, and IGF-I Response Results From the Phase 2 REAL5 Study. The Journal of Clinical Endocrinology & Metabolism. 110(4). 1086–1095. 2 indexed citations

Rutter, Meilan M., et al.. (2023). Successful Treatment of Hypoglycemia With Alpelisib in Pediatric Patients With PIK3CA-Related Overgrowth Spectrum. JCEM Case Reports. 1(2). luad027–luad027. 1 indexed citations

Backeljauw, Philippe, et al.. (2023). Model-Based Analysis of IGF-I Response, Dosing, and Monitoring for Once-Weekly Somapacitan in Children With GH Deficiency. Journal of the Endocrine Society. 7(11). bvad115–bvad115. 10 indexed citations

Wexler, T, Kent Reifschneider, Philippe Backeljauw, et al.. (2023). Growth Hormone Deficiency Following Traumatic Brain Injury in Pediatric and Adolescent Patients: Presentation, Treatment, and Challenges of Transitioning from Pediatric to Adult Services. Journal of Neurotrauma. 40(13-14). 1274–1285. 9 indexed citations

Gutmark‐Little, Iris, et al.. (2023). Current Recommended Estrogen Dosing for Pubertal Induction in Turner Syndrome Results in Normal Uterine Growth. The Journal of Clinical Endocrinology & Metabolism. 109(3). e1040–e1047. 4 indexed citations

Juul, Anders, Philippe Backeljauw, Masanobu Kawai, et al.. (2023). Somapacitan in children born small for gestational age: a multi-centre, open-label, controlled phase 2 study. European Journal of Endocrinology. 188(1). 19–30. 9 indexed citations

Backeljauw, Philippe, Joanne Blair, Nicky Kelepouris, et al.. (2023). Early GH Treatment Is Effective and Well Tolerated in Children With Turner Syndrome: NordiNet® IOS and Answer Program. The Journal of Clinical Endocrinology & Metabolism. 108(10). 2653–2665. 5 indexed citations

Dauber, Andrew, et al.. (2023). Recombinant Human Insulin-Like Growth Factor-1 Treatment of Severe Growth Failure in Three Siblings with STAT5B Deficiency. Hormone Research in Paediatrics. 97(2). 195–202.

Ross, Judith L., Nicky Kelepouris, Nils Krone, et al.. (2023). Factors Associated With Response to Growth Hormone in Pediatric Growth Disorders: Results of a 5-year Registry Analysis. Journal of the Endocrine Society. 7(5). bvad026–bvad026. 7 indexed citations

10.

Juul, Anders, Philippe Backeljauw, Marco Cappa, et al.. (2022). Early Growth Hormone Initiation Leads to Favorable Long-Term Growth Outcomes in Children Born Small for Gestational Age. The Journal of Clinical Endocrinology & Metabolism. 108(5). 1043–1052. 5 indexed citations

11.

Corathers, Sarah, et al.. (2022). Improving Anxiety Screening in Patients with Turner Syndrome. Hormone Research in Paediatrics. 95(1). 68–75. 3 indexed citations

12.

Backeljauw, Philippe, Shankar Kanumakala, Sandro Loche, et al.. (2021). Safety and Effectiveness of Recombinant Human Growth Hormone in Children with Turner Syndrome: Data from the PATRO Children Study. Hormone Research in Paediatrics. 94(3-4). 133–143. 8 indexed citations

13.

Nina, S., Leanne M. Ward, Philippe Backeljauw, et al.. (2020). Long-Term Follow-up of Hypophosphatemic Bone Disease Associated With Elemental Formula Use: Sustained Correction of Bone Disease After Formula Change or Phosphate Supplementation. Clinical Pediatrics. 59(12). 1080–1085. 6 indexed citations

14.

Klein, Karen O., Robert L. Rosenfield, Richard J. Santen, et al.. (2018). Estrogen Replacement in Turner Syndrome: Literature Review and Practical Considerations. The Journal of Clinical Endocrinology & Metabolism. 103(5). 1790–1803. 91 indexed citations

15.

Wittberg, Lisa Prahl, et al.. (2015). Effects of aortic irregularities on blood flow. Biomechanics and Modeling in Mechanobiology. 15(2). 345–360. 32 indexed citations

16.

Shankar, Roopa Kanakatti, Thomas H. Inge, Iris Gutmark‐Little, & Philippe Backeljauw. (2014). Oophorectomy versus salpingo-oophorectomy in Turner syndrome patients with Y-chromosome material: clinical experience and current practice patterns assessment. Journal of Pediatric Surgery. 49(11). 1585–1588. 10 indexed citations

17.

Gutmark, Ephraim, et al.. (2013). Numerical investigation of mass transport through patient-specific deformed aortae. Journal of Biomechanics. 47(2). 544–552. 14 indexed citations

18.

Rosenfeld, Ron G., Stephen M. Rosenthal, Pinchas Cohen, et al.. (2007). Part II: Defining and managing growth hormone treatment failure. Research Explorer (The University of Manchester). 4. 257–268. 1 indexed citations

19.

Rutter, Meilan M., Sampath Prahalad, Murray H. Passo, & Philippe Backeljauw. (2004). Idiopathic Hypercalcemia and Eosinophilic Fasciitis: A Novel Association. Journal of Pediatric Endocrinology and Metabolism. 17(9). 1251–4. 8 indexed citations

20.

Reyes‐Múgica, Miguel, et al.. (2000). Phosphaturic Mesenchymal Tumor-Induced Rickets. Pediatric and Developmental Pathology. 3(1). 61–69. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact